Entries by helene

A Mass Spectrometric-Derived Cell Surface Protein Atlas

Damaris Bausch-Fluck et al. just published a cell surface protein atlas from 41 human and 31 mouse cell types. If gives a fascinating insight in the surfaceome, where the cell interacts with its surroundings and provides targets for many pharmaceutical interventions. http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0121314

Swiss Biotech Day 2015 14 April 2015

Swiss Biotech Day 2015 14 April 2015, Basel Switzerland For a face to face meeting to learn more about Dualsystems and its new technology to identify receptors of your ligand on living cells contact Dr. Paul Helbling via email paul.helbling@dualsystems.com or mobile +41 76 422 55 05

Are research antibodies reliable?

According to a recent comment in Nature by Andrew Bradbury, Andreas Plückthun, and co-signed by 110 other scientist protein-binding reagents (e.g. antibodies) should be defined by their sequences and produced as recombinant proteins to save money and improve reproducibility of published studies (1). Additionally, this will lead to an increased reliability of antibodies used. Already…

Affinity and receptor expression limits tested for LRC-TriCEPS

Dualsystems Biotech AG is testing the limits of the LRC-TriCEPSTM (CaptiRec) technology using antibodies with different affinities against the same target and cells expressing the target receptor with different expression levels. Details of the assesment see here

BIO-Europe Spring® Conference in Paris/France 2015, March 9-11

BIO-Europe Spring® Conference in Paris/France 2015, March 9-11. For a face to face meeting to learn more about Dualsystems and its new technology to identify receptors of your ligand on living cells please send a meeting invitation via the conference partnering system to Dr. Paul Helbling. Alternatively, you can reach Dr. Paul Helbling via email…

CPhI Pharma Insight Briefings 7 – 9 October, Paris, France

Dr. Paul Helbling is speaking at CPhI Pharma Insight Briefings. He presents the LRC-TriCEPS (CaptiRec) technology to identify the receptors of your orphan ligand on the living cells. Thursday 9th October: 12.00 – 12:30, Rooms 520A & 520B (Hall 5) Parc des Expositions To discuss your individual project meet Dr. Paul Helbling in person at Rooms 520A &…

BIO-Europe – Frankfurt, Germany, November 3 – November 5, 2014

BIO–Europe – Building value through partnerships, Frankfurt, Germany, November 3 – November 5, 2014. For a face to face meeting to learn more about Dualsystems and its new technology to identify receptors of your ligand on living cells contact Dr. Paul Helbling via email paul.helbling@dualsystems.com or mobile +41 76 422 55 05

Video – how the LRC-TriCEPS technology works

Dualsystems Biotech AG Press Release How the LRC-TriCEPS technology works (Video) Zürich Switzerland – June 23, 2014 – Dualsystems Biotech AG offers the most advanced technology for identifying receptor(s) for orphan ligands. The ligand-receptor capture technology (LRC-TriCEPS) is an innovative and conceptually new approach for the unbiased discovery of cell surface interactions of ligands ranging…